MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
MiR-150 promotes cellular metastasis in non-small cell lung cancer by targeting FOXO4
Authors
Keywords
-
Journal
Scientific Reports
Volume 6, Issue 1, Pages -
Publisher
Springer Nature
Online
2016-12-15
DOI
10.1038/srep39001
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Knockout of 4.1B triggers malignant transformation in SV40T-immortalized mouse embryo fibroblast cells
- (2016) Zi Wang et al. MOLECULAR CARCINOGENESIS
- MicroRNA-150 suppresses cell proliferation and metastasis in hepatocellular carcinoma by inhibiting the GAB1-ERK axis
- (2016) Wei Sun et al. Oncotarget
- The role of microRNA-1274a in the tumorigenesis of gastric cancer: Accelerating cancer cell proliferation and migration via directly targeting FOXO4
- (2015) Guo-Jun Wang et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- microRNA-150 promotes cervical cancer cell growth and survival by targeting FOXO4
- (2015) Jun Li et al. BMC MOLECULAR BIOLOGY
- FOXO3a modulates WNT/β-catenin signaling and suppresses epithelial-to-mesenchymal transition in prostate cancer cells
- (2015) Hao Liu et al. CELLULAR SIGNALLING
- Foxo3a-mediated overexpression of microRNA-622 suppresses tumor metastasis by repressing hypoxia-inducible factor-1α in ERK-responsive lung cancer
- (2015) Chun-Wen Cheng et al. Oncotarget
- Genome-wide endogenous DAF-16/FOXO recruitment dynamics during lowered insulin signalling in C. elegans
- (2015) Neeraj Kumar et al. Oncotarget
- miR-150 inhibits terminal erythroid proliferation and differentiation
- (2015) Zhiwei Sun et al. Oncotarget
- Protein 4.1N acts as a potential tumor suppressor linking PP1 to JNK-c-Jun pathway regulation in NSCLC
- (2015) Zi Wang et al. Oncotarget
- Molecular pathways and therapeutic targets in lung cancer
- (2015) Emma Shtivelman et al. Oncotarget
- microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers
- (2015) Pierluigi Gasparini et al. Oncotarget
- The transcription factor FOXO4 is down-regulated and inhibits tumor proliferation and metastasis in gastric cancer
- (2014) Linna Su et al. BMC CANCER
- Cancer treatment and survivorship statistics, 2014
- (2014) Carol E. DeSantis et al. CA-A CANCER JOURNAL FOR CLINICIANS
- Cancer statistics, 2014
- (2014) Rebecca Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- FOXO1 3′UTR functions as a ceRNA in repressing the metastases of breast cancer cells via regulating miRNA activity
- (2014) Jue Yang et al. FEBS LETTERS
- A Genome-Wide RNAi Screen Identifies FOXO4 as a Metastasis-Suppressor through Counteracting PI3K/AKT Signal Pathway in Prostate Cancer
- (2014) Bing Su et al. PLoS One
- MicroRNAs in cancer: biomarkers, functions and therapy
- (2014) Josie Hayes et al. TRENDS IN MOLECULAR MEDICINE
- Down-regulation of miR-150 induces cell proliferation inhibition and apoptosis in non-small-cell lung cancer by targeting BAK1 in vitro
- (2014) Xiao-yan Gu et al. TUMOR BIOLOGY
- FoxO transcription factors: their roles in the maintenance of skeletal muscle homeostasis
- (2013) Anthony M. J. Sanchez et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- miR-150 promotes the proliferation of lung cancer cells by targetingP53
- (2013) Ni Zhang et al. FEBS LETTERS
- FOXOs: signalling integrators for homeostasis maintenance
- (2013) Astrid Eijkelenboom et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- The role of miR-150 in normal and malignant hematopoiesis
- (2013) Y He et al. ONCOGENE
- miR-150 Promotes Human Breast Cancer Growth and Malignant Behavior by Targeting the Pro-Apoptotic Purinergic P2X7 Receptor
- (2013) Songyin Huang et al. PLoS One
- MiR-150is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducerZEB1
- (2012) Takehiko Yokobori et al. CANCER SCIENCE
- EMT-activating transcription factors in cancer: beyond EMT and tumor invasiveness
- (2012) Ester Sánchez-Tilló et al. CELLULAR AND MOLECULAR LIFE SCIENCES
- Expression of miR-150 and miR-3940-5p is reduced in non-small cell lung carcinoma and correlates with clinicopathological features
- (2012) YIFENG SUN et al. ONCOLOGY REPORTS
- MicroRNAs – Important Molecules in Lung Cancer Research
- (2012) Petra Leidinger et al. Frontiers in Genetics
- MicroRNAs: critical regulators of epithelial to mesenchymal (EMT) and mesenchymal to epithelial transition (MET) in cancer progression
- (2011) Marc D. Bullock et al. BIOLOGY OF THE CELL
- MicroRNA-150 directly targets MUC4 and suppresses growth and malignant behavior of pancreatic cancer cells
- (2011) Sanjeev K. Srivastava et al. CARCINOGENESIS
- microRNA-499-5p promotes cellular invasion and tumor metastasis in colorectal cancer by targeting FOXO4 and PDCD4
- (2011) Xiangqiang Liu et al. CARCINOGENESIS
- The diversity of sex steroid action: the role of micro-RNAs and FOXO transcription factors in cycling endometrium and cancer
- (2011) Eric W-F Lam et al. JOURNAL OF ENDOCRINOLOGY
- MiR-150 promotes gastric cancer proliferation by negatively regulating the pro-apoptotic gene EGR2
- (2010) Qiong Wu et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- Dual role of NO donors in the reversal of tumor cell resistance and EMT: Downregulation of the NF-κB/Snail/YY1/RKIP circuitry
- (2010) Benjamin Bonavida et al. NITRIC OXIDE-BIOLOGY AND CHEMISTRY
- ANXA8 Down-regulation by EGF-FOXO4 Signaling Is Involved in Cell Scattering and Tumor Metastasis of Cholangiocarcinoma
- (2009) Mi–Jin Lee et al. GASTROENTEROLOGY
- FoxO4 Inhibits NF-κB and Protects Mice Against Colonic Injury and Inflammation
- (2009) Wen Zhou et al. GASTROENTEROLOGY
- FOXOs, cancer and regulation of apoptosis
- (2008) Z Fu et al. ONCOGENE
Create your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started